Grace Xu

Counsel

Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.

pdf

Grace Xu focuses her practice on capital markets, cross-border public and private M&A, venture capital/private equity financings, and regulatory compliance.

Prior to joining O’Melveny, Grace worked at another international law firm in its Hong Kong office.

Languages

  • English
  • Mandarin Chinese
  • Cantonese

Admissions

  • New York
  • Hong Kong (Registered Foreign Lawyer)

Education

  • Duke Law School, LL.M.
  • University of Hong Kong, M.C.L.

M&A

  • A buyer consortium led by Yunfeng Capital, TF Capital, GIC and management in connection with the acquisition of Cellular Biomedicine Group in a “going private” transaction valued at approximately US$380 million
  • GIC in connection with its investment in Genpact Ltd.
  • Yunfeng Capital in its investment in WuXi Diagnostic Investment (Cayman) Limited
  • SEEK Limited in its investment in Coursera, Inc., an online learning platform in California, U.S.
  • SEEK Limited in its investment in Educalcp II, S.A. de C.V., an online-education service provider in Mexico
  • a buyer group led by SEEK Limited and including Hillhouse Capital and FountainVest Partners in the acquisition of Zhaopin Limited (NASDAQ:ZPIN) in a transaction valued at over US$1 billion
  • Weichai Power in its US$183million investment in and joint venture with Ballard Power Systems, a leading global innovative clean energy fuel cell solutions provider dual-listed on Toronto Stock Exchange and Nasdaq
  • Founders of Adicon Holdings Limited in the sale of a majority interest to a consortium comprised of Meinian Onehealth Healthcare, funds managed by the Caryle Group, and Carlyle co-investors
  • Focus Media Holding Limited (NASDAQ:FMCN) in its US$3.5 billion going-private transaction
VIEW MORE